136 related articles for article (PubMed ID: 34214737)
1. Local Radiation Therapy Before and During Induction Delays Stem Cell Mobilization and Collection in Multiple Myeloma Patients.
Sauer S; Erdmann K; Jensen AD; Wennmann M; Pavel P; Jordan K; Schmitt A; Kriegsmann M; Wuchter P; Goldschmidt H; Müller-Tidow C; Kriegsmann K
Transplant Cell Ther; 2021 Oct; 27(10):876.e1-876.e11. PubMed ID: 34214737
[TBL] [Abstract][Full Text] [Related]
2. Impact of Clinical Parameters and Induction Regimens on Peripheral Blood Stem-Cell Mobilization and Collection in Multiple Myeloma Patients.
Sauer S; Hieke L; Brandt J; Müller-Tidow C; Schmitt A; Kauer J; Kriegsmann K
Transfus Med Hemother; 2023 Oct; 50(5):382-395. PubMed ID: 37899996
[TBL] [Abstract][Full Text] [Related]
3. Stem cell collection after lenalidomide, bortezomib and dexamethasone plus elotuzumab or isatuximab in newly diagnosed multiple myeloma patients: a single centre experience from the GMMG-HD6 and -HD7 trials.
Kauer J; Freundt EP; Schmitt A; Weinhold N; Mai EK; Müller-Tidow C; Goldschmidt H; Raab MS; Kriegsmann K; Sauer S
BMC Cancer; 2023 Nov; 23(1):1132. PubMed ID: 37990162
[TBL] [Abstract][Full Text] [Related]
4. Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of patients with multiple myeloma.
Lemoli RM; Cavo M; Fortuna A
J Hematother; 1996 Aug; 5(4):339-49. PubMed ID: 8877709
[TBL] [Abstract][Full Text] [Related]
5. Low-dose cyclophosphamide effectively mobilizes peripheral blood stem cells in patients with autoimmune disease.
Blank N; Lisenko K; Pavel P; Bruckner T; Ho AD; Wuchter P
Eur J Haematol; 2016 Jul; 97(1):78-82. PubMed ID: 26381040
[TBL] [Abstract][Full Text] [Related]
6. Autologous Stem Cell Collection after Daratumumab, Bortezomib, Thalidomide, and Dexamethasone versus Bortezomib, Cyclophosphamide, and Dexamethasone in Newly Diagnosed Multiple Myeloma.
Sauer S; Kriegsmann K; Nientiedt C; Schmitt A; Müller-Tidow C; Raab MS; Kauer J
Transfus Med Hemother; 2023 Oct; 50(5):371-381. PubMed ID: 37936633
[TBL] [Abstract][Full Text] [Related]
7. Factors influencing collection of peripheral blood stem cells in patients with multiple myeloma.
Demirer T; Buckner CD; Gooley T; Appelbaum FR; Rowley S; Chauncey T; Lilleby K; Storb R; Bensinger WI
Bone Marrow Transplant; 1996 Jun; 17(6):937-41. PubMed ID: 8807097
[TBL] [Abstract][Full Text] [Related]
8. Pegylated Filgrastim Versus Filgrastim for Stem Cell Mobilization in Multiple Myeloma After Novel Agent Induction.
Abid MB; De Mel S; Abid MA; Yap ES; Gopalakrishnan SK; Chen Y; Yuen YC; Wong HC; Lin A; Poon LM; Koh LP; Chng WJ; Tan LK
Clin Lymphoma Myeloma Leuk; 2018 Mar; 18(3):174-179. PubMed ID: 29398647
[TBL] [Abstract][Full Text] [Related]
9. Collection of more hematopoietic progenitor cells with large volume leukapheresis in patients with multiple myeloma.
Desikan KR; Jagannath S; Siegel D; Nelson J; Bracy D; Barlogie B; Tricot G
Leuk Lymphoma; 1998 Feb; 28(5-6):501-8. PubMed ID: 9613979
[TBL] [Abstract][Full Text] [Related]
10. Orchestration of Chemomobilization and G-CSF Administration for Successful Hematopoietic Stem Cell Collection.
Kriegsmann K; Schmitt A; Kriegsmann M; Bruckner T; Anyanwu A; Witzens-Harig M; Müller-Tidow C; Klein S; Wuchter P
Biol Blood Marrow Transplant; 2018 Jun; 24(6):1281-1288. PubMed ID: 29353110
[TBL] [Abstract][Full Text] [Related]
11. Successful collection of peripheral blood stem cells upon VIDE chemomobilization in sarcoma patients.
Kriegsmann K; Heilig C; Cremer M; Novotny P; Kriegsmann M; Bruckner T; Müller-Tidow C; Egerer G; Wuchter P
Eur J Haematol; 2017 Nov; 99(5):459-464. PubMed ID: 28884875
[TBL] [Abstract][Full Text] [Related]
12. First and second apheresis in patients with multiple myeloma: no differences in tumor load and hematopoietic stem cell yield.
Kiel K; Cremer FW; Ehrbrecht E; Wallmeier M; Hegenbart U; Goldschmidt H; Moos M
Bone Marrow Transplant; 1998 Jun; 21(11):1109-15. PubMed ID: 9645573
[TBL] [Abstract][Full Text] [Related]
13. Comparison of two leukapheresis programs for computerized collection of blood progenitor cells on a new cell separator.
Schwella N; Movassaghi K; Scheding S; Ahrens N; Salama A
Transfusion; 2003 Jan; 43(1):58-64. PubMed ID: 12519431
[TBL] [Abstract][Full Text] [Related]
14. Third time's a charm? Mobilization of autologous peripheral blood stem cells in patients with two previous failed mobilizations with plerixafor.
Zhuang L; Boriboonnangkul P; Wang S; Yuan S
Transfusion; 2020 Jun; 60(6):1253-1259. PubMed ID: 32483875
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Different Stem Cell Mobilization Regimens in AL Amyloidosis Patients.
Lisenko K; Wuchter P; Hansberg M; Mangatter A; Benner A; Ho AD; Goldschmidt H; Hegenbart U; Schönland S
Biol Blood Marrow Transplant; 2017 Nov; 23(11):1870-1878. PubMed ID: 28754546
[TBL] [Abstract][Full Text] [Related]
16. Low-dose peripheral blood stem cell graft after high-dose chemotherapy - an evaluation of hematopoietic reconstitution.
Sauer S; Pavel P; Schmitt A; Cremer M; Kriegsmann M; Bruckner T; Jordan K; Wuchter P; Müller-Tidow C; Kriegsmann K
BMC Cancer; 2020 Apr; 20(1):353. PubMed ID: 32334570
[TBL] [Abstract][Full Text] [Related]
17. Blood stem cell collection using chemotherapy with or without systematic G-CSF: experience in 52 patients with multiple myeloma.
Lefrere F; Makke J; Fermand J; Marolleau J; Dal Cortivo L; Alberti C; Mouton V; Benbunan M; Miclea J
Bone Marrow Transplant; 1999 Sep; 24(5):463-6. PubMed ID: 10482928
[TBL] [Abstract][Full Text] [Related]
18. Comparison of biosimilar filgrastim, originator filgrastim, and lenograstim for autologous stem cell mobilization in patients with multiple myeloma.
Lisenko K; Baertsch MA; Meiser R; Pavel P; Bruckner T; Kriegsmann M; Schmitt A; Witzens-Harig M; Ho AD; Hillengass J; Wuchter P
Transfusion; 2017 Oct; 57(10):2359-2365. PubMed ID: 28653421
[TBL] [Abstract][Full Text] [Related]
19. Poor peripheral blood stem cell mobilization affects long-term outcomes in multiple myeloma patients undergoing autologous stem cell transplantation.
Moreb JS; Byrne M; Shugarman I; Zou F; Xiong S; May WS; Norkin M; Hiemenz J; Brown R; Cogle C; Wingard JR; Hsu JW
J Clin Apher; 2018 Feb; 33(1):29-37. PubMed ID: 28556233
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of vinorelbine plus granulocyte colony-stimulation factor for CD34+ hematopoietic progenitor cell mobilization in patients with multiple myeloma.
Samaras P; Pfrommer S; Seifert B; Petrausch U; Mischo A; Schmidt A; Schanz U; Nair G; Bargetzi M; Taverna C; Stupp R; Stenner-Liewen F; Renner C
Biol Blood Marrow Transplant; 2015 Jan; 21(1):74-80. PubMed ID: 25278456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
